↓ Skip to main content

Fedratinib: First Approval

Overview of attention for article published in Drugs, September 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
Fedratinib: First Approval
Published in
Drugs, September 2019
DOI 10.1007/s40265-019-01205-x
Authors

Hannah A. Blair

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2019.
All research outputs
#10,907,179
of 13,716,038 outputs
Outputs from Drugs
#2,263
of 2,519 outputs
Outputs of similar age
#148,038
of 206,092 outputs
Outputs of similar age from Drugs
#15
of 23 outputs
Altmetric has tracked 13,716,038 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,519 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,092 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.